Shanghai Shyndec Pharmaceutical (600420.SH): The efficacy of enalapril maleate tablets was evaluated through consistency assessment.
Guoyao Xian Dai (600420.SH) announcement, the company has received the approval and issuance of the "Supplementary Drug..." from the State Food and Drug Administration.
Shanghai Shyndec Pharmaceutical (600420.SH) announced that the company has received the Drug Supplementary Application Approval Notice issued by the National Medical Products Administration, approving the consistency evaluation of the generic quality and efficacy of 5mg perindopril maleate tablets. Perindopril maleate is an angiotensin-converting enzyme inhibitor mainly used to treat primary hypertension, renal vascular hypertension, and symptomatic heart failure.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


